When applied topically or injected directly into the skin, exosomes can stimulate collagen and elastin production, reducing wrinkles, scarring, and other signs of aging
The Phase 2/3 LIFT-AD trial (NCT04488419), evaluating once-daily subcutaneous fosgonimeton 40 mg versus placebo in 312 participants with mild-to-moderate Alzheimers disease over 26 weeks, failed its primary endpoint (Global Statistical Test composite of ADAS-Cog11 and ADCS-ADL23) and its key secondary endpoints when results were announced in September 2024
NAD IV Therapy: Benefits, Risks, and What to Expect from This Cellular Health Treatment. NAD IV Therapy: Benefits, Risks, and What to Expect from This Cellular Health Treatment Tenrio, Micaely Cristina dos Santos, et al
Eur J Neurosci 54(6):63046321
If we take binders too close to our glutathione supplement, the binder may bind to the glutathione, making it ineffective